|
US4835251A
(en)
|
1986-06-23 |
1989-05-30 |
Genetech, Inc. |
Method of chain combination
|
|
WO2007115414A1
(en)
|
2006-04-11 |
2007-10-18 |
University Of Guelph |
Modified h2 relaxin for tumor suppression
|
|
CA2704246A1
(en)
|
2007-10-30 |
2009-05-07 |
Howard Florey Institute Of Experimental Physiology And Medicine |
Chimeric relaxin polypeptides comprising an a and b chain derived from different relaxin family peptides
|
|
WO2010105081A1
(en)
|
2009-03-13 |
2010-09-16 |
Medtronic, Inc. |
Method of treating heart failure
|
|
US8389475B2
(en)
|
2009-08-10 |
2013-03-05 |
The Board Of Trustees Of The Leland Stanford Junior University |
Relaxin analogs
|
|
US20110245469A1
(en)
|
2010-04-02 |
2011-10-06 |
Athena Discovery, Inc. |
Intermediates formed in biosynthesis of relaxin-fusion proteins with extended in vivo half-lives
|
|
PE20140160A1
(es)
|
2010-08-17 |
2014-02-08 |
Ambrx Inc |
Polipeptidos de relaxina modificados y sus usos
|
|
US9567386B2
(en)
|
2010-08-17 |
2017-02-14 |
Ambrx, Inc. |
Therapeutic uses of modified relaxin polypeptides
|
|
WO2012031327A1
(en)
|
2010-09-08 |
2012-03-15 |
Howard Florey Institute Of Experimental Physiology And Medicine |
Modified relaxin polypeptides
|
|
GB201110833D0
(en)
|
2011-06-24 |
2011-08-10 |
Bold Venture Llc |
Compositions
|
|
AU2012280474A1
(en)
|
2011-07-01 |
2014-01-16 |
Bayer Intellectual Property Gmbh |
Relaxin fusion polypeptides and uses thereof
|
|
AU2012283235A1
(en)
|
2011-07-08 |
2014-01-09 |
Bayer Intellectual Property Gmbh |
Fusion proteins releasing Relaxin and uses thereof
|
|
AU2012291972B2
(en)
|
2011-08-04 |
2017-03-09 |
Pharis Biotec Gmbh |
Process for preparing human relaxin-2
|
|
EP2630964A1
(en)
|
2012-02-22 |
2013-08-28 |
Immundiagnostik AG |
Method and medicament for treating patients in risk of prediabetes and type-2 diabetes
|
|
WO2013177529A1
(en)
|
2012-05-24 |
2013-11-28 |
Angion Biomedica Corp. |
Relaxin-like compounds and uses thereof
|
|
US20160060322A1
(en)
|
2012-09-10 |
2016-03-03 |
Angion Biomedica Corp. |
Relaxin-like peptides and uses thereof
|
|
US9381231B2
(en)
|
2012-10-09 |
2016-07-05 |
University Of Florida Research Foundation, Inc. |
Use of relaxin to restore maternal physiology in pregnancies conceived by assisted reproductive technologies
|
|
US20150232526A1
(en)
|
2012-10-10 |
2015-08-20 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Use of relaxin to treat atrial fibrillation
|
|
US9005630B2
(en)
|
2012-11-01 |
2015-04-14 |
Veterinaerinstituttet |
Fusion proteins for the treatment of allergic diseases
|
|
US9907833B2
(en)
|
2013-07-25 |
2018-03-06 |
University Of Florida Research Foundation, Incorporated |
Use of relaxin to treat placental syndromes
|
|
WO2015038938A1
(en)
|
2013-09-13 |
2015-03-19 |
The California Institute For Biomedical Research |
Modified therapeutic agents and compositions thereof
|
|
JP6694381B2
(ja)
|
2013-09-24 |
2020-05-13 |
エラスタジェン・プロプライエタリー・リミテッドElastagen Pty Ltd |
タンパク質抽出方法
|
|
WO2015073727A1
(en)
|
2013-11-13 |
2015-05-21 |
Aequus Biopharma, Inc. |
Engineered glycoproteins and uses thereof
|
|
EP3083977B1
(en)
*
|
2013-12-20 |
2018-02-28 |
F. Hoffmann-La Roche AG |
Improved recombinant polypeptide production methods
|
|
CA2945838C
(en)
|
2014-04-17 |
2022-08-16 |
The Florey Institute Of Neuroscience And Mental Health |
Modified relaxin b chain peptides
|
|
EP2946788A1
(en)
|
2014-05-23 |
2015-11-25 |
Immundiagnostik AG |
Method and composition for treating heart failure with preserved ejection fraction
|
|
WO2016144968A1
(en)
|
2015-03-09 |
2016-09-15 |
University Of Washington |
Relaxin therapy for disorders of the diaphragm
|
|
GB201516068D0
(en)
|
2015-09-10 |
2015-10-28 |
Biomed Ltd B V |
Novel therapy
|
|
US11161891B2
(en)
|
2015-12-09 |
2021-11-02 |
The Scripps Research Institute |
Relaxin immunoglobulin fusion proteins and methods of use
|
|
CN115837014A
(zh)
|
2016-05-18 |
2023-03-24 |
摩登纳特斯有限公司 |
编码松弛素的多核苷酸
|
|
US20190307811A1
(en)
|
2016-08-04 |
2019-10-10 |
Hudson Institute of Medical Research |
Method for treating airways disease
|
|
EP3522911B1
(en)
|
2016-10-07 |
2021-12-08 |
Beth Israel Deaconess Medical Center, Inc. |
Compositions comprising relaxin and methods of use thereof
|
|
WO2018138170A1
(en)
*
|
2017-01-25 |
2018-08-02 |
Medimmune, Llc |
Relaxin fusion polypeptides and uses thereof
|
|
SG10201912034UA
(en)
|
2017-02-08 |
2020-02-27 |
Bristol Myers Squibb Co |
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
|
|
TW201934572A
(zh)
|
2018-01-31 |
2019-09-01 |
法商賽諾菲公司 |
經修飾之鬆弛素b鏈胜肽及其治療用途
|
|
MY199821A
(en)
|
2018-01-31 |
2023-11-23 |
Sanofi Sa |
Modified lipidated relaxin b chain peptides and their therapeutic use
|
|
WO2019149781A1
(en)
|
2018-01-31 |
2019-08-08 |
Sanofi |
Modified lipidated relaxin b chain peptides and their therapeutic use
|
|
TWI844709B
(zh)
|
2019-07-31 |
2024-06-11 |
美商美國禮來大藥廠 |
鬆弛素(relaxin)類似物及其使用方法
|
|
EP4058048A1
(en)
|
2019-11-16 |
2022-09-21 |
Relaxera Pharmazeutische Gesellschaft mbH & Co. KG |
Medical composition for treating cardiac wasting and cachexia
|
|
JP2023524981A
(ja)
*
|
2020-05-08 |
2023-06-14 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
操作されたリラキシンおよびその使用の方法
|
|
EP4153214A4
(en)
|
2020-05-22 |
2024-06-26 |
Trustees of Boston University |
Methods and compositions for treating a fibrotic disease
|
|
WO2021247475A1
(en)
|
2020-06-02 |
2021-12-09 |
Trustees Of Boston University |
Production of soluble relaxin and relaxin analogs
|
|
CR20230015A
(es)
|
2020-06-17 |
2023-02-17 |
Medimmune Ltd |
Fusiones heterodiméricas de relaxina y usos de las mismas
|
|
CN114075276A
(zh)
|
2020-08-17 |
2022-02-22 |
成都奥达生物科技有限公司 |
一种长效松弛素2类似物
|
|
CN113577289A
(zh)
|
2021-01-11 |
2021-11-02 |
张莉 |
Rxfp1/3抑制剂在制备预防或治疗青少年特发性脊柱侧凸疾病的药物中的用途
|
|
WO2023028008A2
(en)
|
2021-08-23 |
2023-03-02 |
River 2 Renal Corp. |
Combination of relaxin and vasopressin analogues for treatment of renal disorders or conditions
|
|
EP4402474A1
(en)
|
2021-09-14 |
2024-07-24 |
Bellylabs OY |
Assay method for relaxin
|
|
US20250017867A1
(en)
|
2021-10-01 |
2025-01-16 |
Modernatx, Inc. |
Polynucleotides encoding relaxin for the treatment of fibrosis and/or cardiovascular disease
|
|
WO2023086913A2
(en)
|
2021-11-11 |
2023-05-19 |
Tectonic Therapeutic, Inc. |
Relaxin-2 fusion protein analogs and methods of using same
|
|
JP2024546877A
(ja)
|
2021-12-15 |
2024-12-26 |
メドイミューン・リミテッド |
ヘテロ二量体リラキシン融合物を使用した治療
|
|
JP2025517100A
(ja)
|
2022-05-07 |
2025-06-03 |
北京拓界生物医薬科技有限公司 |
リラキシン又は類似体の融合タンパク質及びその医薬的使用
|
|
JP2025528469A
(ja)
|
2022-08-31 |
2025-08-28 |
リラクセラ ファルマツォイティッシュ ゲゼルシャフト エムベーハー ウント コー. カーゲー |
免疫抑制薬及び処置方法
|
|
EP4713001A2
(en)
*
|
2023-05-18 |
2026-03-25 |
Tectonic Operating Company, Inc. |
Relaxin-2 fusion protein analogs and methods of using same
|